Natalie Sutkowski

1.1k total citations
23 papers, 853 citations indexed

About

Natalie Sutkowski is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Natalie Sutkowski has authored 23 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Natalie Sutkowski's work include Viral-associated cancers and disorders (7 papers), Cytomegalovirus and herpesvirus research (7 papers) and CAR-T cell therapy research (5 papers). Natalie Sutkowski is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Cytomegalovirus and herpesvirus research (7 papers) and CAR-T cell therapy research (5 papers). Natalie Sutkowski collaborates with scholars based in United States, Switzerland and Canada. Natalie Sutkowski's co-authors include Brigitte T. Huber, Bernard Conrad, Gang Chen, Germán Calderón, Cristina Ciurli, David A. Thorley‐Lawson, Rafick‐Pierre Sékaly, Ping‐Ning Hsu, M. Boyd Gillespie and Françoise Meylan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Natalie Sutkowski

22 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Sutkowski United States 13 322 269 256 211 209 23 853
Howard B. Urnovitz United States 17 185 0.6× 328 1.2× 131 0.5× 323 1.5× 92 0.4× 41 973
Emanuele Marchi United Kingdom 15 350 1.1× 242 0.9× 112 0.4× 152 0.7× 146 0.7× 28 887
R. Hehlmann Germany 16 169 0.5× 247 0.9× 111 0.4× 326 1.5× 167 0.8× 30 859
Aleida M. Bakker Netherlands 15 714 2.2× 200 0.7× 71 0.3× 122 0.6× 142 0.7× 20 1.2k
Hidemi Toyoda Japan 18 264 0.8× 325 1.2× 47 0.2× 157 0.7× 117 0.6× 63 956
Werner Vogetseder Austria 11 184 0.6× 127 0.5× 94 0.4× 55 0.3× 76 0.4× 19 448
Ronald Jubin United States 15 295 0.9× 718 2.7× 52 0.2× 229 1.1× 329 1.6× 26 1.4k
Hsin‐Pai Li Taiwan 15 156 0.5× 409 1.5× 26 0.1× 295 1.4× 87 0.4× 29 943
J. M. Seigneurin France 13 120 0.4× 72 0.3× 39 0.2× 226 1.1× 217 1.0× 26 608
David N. Everly United States 14 335 1.0× 388 1.4× 21 0.1× 364 1.7× 482 2.3× 18 1.0k

Countries citing papers authored by Natalie Sutkowski

Since Specialization
Citations

This map shows the geographic impact of Natalie Sutkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Sutkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Sutkowski more than expected).

Fields of papers citing papers by Natalie Sutkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Sutkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Sutkowski. The network helps show where Natalie Sutkowski may publish in the future.

Co-authorship network of co-authors of Natalie Sutkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Sutkowski. A scholar is included among the top collaborators of Natalie Sutkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Sutkowski. Natalie Sutkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomar, Swati, Diego Altomare, Sangeeta Kowli, et al.. (2015). Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients. Head & Neck. 38(S1). E694–704. 32 indexed citations
2.
Sutkowski, Natalie, Wei Sun, & Daniel Fernandes. (2015). Antibody immunotherapy targeting the self-tumor antigen nucleolin (VAC5P.1129). The Journal of Immunology. 194(1_Supplement). 73.14–73.14. 1 indexed citations
3.
Byrd, J. Kenneth, M. Taylor Fordham, Theodore R. McRackan, et al.. (2012). Predicting HPV Status in Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 138(12). 1155–1155. 12 indexed citations
4.
Gillespie, M. Boyd, et al.. (2009). Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009. Current Treatment Options in Oncology. 10(5-6). 296–307. 38 indexed citations
5.
Tai, Albert, et al.. (2008). EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology. 385(1). 261–266. 49 indexed citations
6.
Tai, Albert, et al.. (2006). Murine Vβ3+ and Vβ7+ T Cell Subsets Are Specific Targets for the HERV-K18 Env Superantigen. The Journal of Immunology. 177(5). 3178–3184. 14 indexed citations
7.
Sutkowski, Natalie, et al.. (2005). Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis.. PubMed. 32(9). 1821–31. 54 indexed citations
8.
Sutkowski, Natalie, Gang Chen, Germán Calderón, & Brigitte T. Huber. (2004). Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen. Journal of Virology. 78(14). 7852–7860. 78 indexed citations
9.
Sutkowski, Natalie & Brigitte T. Huber. (2003). Assessment of Specific T-Cell Activation by Superantigens. Humana Press eBooks. 214. 185–217. 2 indexed citations
10.
Marguerat, Samuel, Françoise Meylan, Catherine Ucla, et al.. (2001). Interferon-α-Induced Endogenous Superantigen. Immunity. 15(4). 591–601. 115 indexed citations
11.
Hsu, Ping‐Ning, et al.. (2001). Association of Mouse Mammary Tumor Virus Superantigen with MHC Class II During Biosynthesis. The Journal of Immunology. 166(5). 3309–3314. 10 indexed citations
12.
Sutkowski, Natalie, et al.. (2001). Epstein-Barr Virus Transactivates the Human Endogenous Retrovirus HERV-K18 that Encodes a Superantigen. Immunity. 15(4). 579–589. 243 indexed citations
13.
Chen, Chiann-Chyi, et al.. (1998). Long-Term Contribution to the Myeloid Compartment by Lineage-Committed Stem Cells. Blood. 92(9). 3210–3217. 3 indexed citations
14.
Sutkowski, Natalie, et al.. (1996). The interplay of herpesviruses in AIDS: superantigen sharing. Trends in Microbiology. 4(3). 89–91. 2 indexed citations
15.
Sutkowski, Natalie, et al.. (1996). An Epstein-Barr virus-associated superantigen.. The Journal of Experimental Medicine. 184(3). 971–980. 111 indexed citations
16.
Huber, Brigitte T., et al.. (1996). Virus-encoded superantigens.. Microbiological Reviews. 60(3). 473–482. 16 indexed citations
17.
Gu, Jiang, et al.. (1996). A murine model for genetic manipulation of the T cell compartment.. PubMed. 24(12). 1432–40. 4 indexed citations
18.
Sutkowski, Natalie, et al.. (1995). A peripheral blood-derived monolayer supports long-term cultures of human CD4+ and CD8+ T lymphocytes. Blood. 85(11). 3213–3222. 6 indexed citations
19.
Sutkowski, Natalie, Ming‐Ling Kuo, Alfredo Varela‐Echavarría, Joseph P. Dougherty, & Yacov Ron. (1994). A murine model for B-lymphocyte somatic cell gene therapy.. Proceedings of the National Academy of Sciences. 91(19). 8875–8879. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026